3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
39
Rectal Neoplasms
11
Colonic Neoplasms
11
Neoplasms
10
Neoplasm Metastasis
9
Stomach Neoplasms
4
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Pancreatic Neoplasms
2
Lung Neoplasms
2
Adenocarcinoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Exanthema
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Carcinoma, Basal Cell
1
Carcinoma
1
Breast Neoplasms
1
Advanced Cancer
1
Interventions
dexpanthenol
1
Triamcinolone Acetonide
1
Tetracycline
1
Provitamins
1
Prednisone
1
Panitumumab
1
Minocycline
1
Irinotecan
1
IFL protocol
1
Hydrocortisone
1
Gels
1
Erlotinib Hydrochloride
1
Doxycycline
1
Dapsone
1
Clindamycin
1
Anti-Bacterial Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Exanthema
×
IFL protocol
×
Clear all
NCT00332163
2016-02-23
STEPP
Amgen
Phase 2
Completed
95 enrolled
23 charts